AI assistant
Chemours Co — Director's Dealing 2015
Jul 7, 2015
31561_dirs_2015-07-06_4ae84e28-c176-4307-90b5-2e2332441864.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2015-07-01
Reporting Person: Vanlancker Thierry FJ (President - Fluoroproducts)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-01 | Common Stock, par value $.01 | A | 138019 | $0.00 | Acquired | 140972 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-01 | Stock Option (Right to Buy) | $11.8693 | A | 32678 | Acquired | 2020-02-05 | Common Stock (32678) | Direct |
| 2015-07-01 | Stock Option (Right to Buy) | $15.4871 | A | 25568 | Acquired | 2021-02-04 | Common Stock (25568) | Direct |
| 2015-07-01 | Stock Option (Right to Buy) | $18.4494 | A | 30152 | Acquired | 2022-02-03 | Common Stock (30152) | Direct |
Footnotes
F1: Represents restricted stock units granted in accordance with the Employee Matters Agreement (the "Agreement") dated as of June 26, 2015 between the Issuer and E. I. du Pont de Nemours and Company ("DuPont") to replace restricted stock units and related dividend equivalent units of DuPont held by the Reporting Person immediately before the legal and structural separation of Issuer from DuPont (the "Spin-off").
F2: Includes shares of Issuer common stock received in connection with the Spin-off in an exempt transaction pursuant to Rule 16a-9 based on preliminary information regarding the Spin-off. Final amounts, if different, will be reported in a subsequent filing.
F3: Award replaces stock options of DuPont held by the Reporting Person immediately before the Spin-off pursuant to the Agreement. Information reported in this row is estimated as of July 6, 2015 based on preliminary information regarding the Spinoff. Final information, if different, will be reported in a subsequent filing.
F4: Includes 21,785 options to purchase shares of Issuer common stock that are immediately exercisable. The remaining options vest on February 6, 2016.
F5: Includes 8,523 options to purchase shares of Issuer common stock that are immediately exercisable. The remaining options vest in two approximately equal annual installments beginning February 5, 2016.
F6: Options to purchase shares of Issuer common stock vest in three approximately equal annual installments beginning February 4, 2016.